ArchPoint Investors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.12M | Hold |
16,750
| – | – | 0.62% | 36 |
|
2025
Q1 | $2.14M | Buy |
16,750
+750
| +5% | +$95.9K | 0.7% | 33 |
|
2024
Q4 | $2.12M | Sell |
16,000
-750
| -4% | -$99.2K | 0.69% | 32 |
|
2024
Q3 | $2.44M | Hold |
16,750
| – | – | 0.81% | 30 |
|
2024
Q2 | $2.3M | Hold |
16,750
| – | – | 0.86% | 35 |
|
2024
Q1 | $2.3M | Buy |
+16,750
| New | +$2.3M | 0.96% | 30 |
|
2020
Q2 | – | Sell |
-6,180
| Closed | -$666K | – | 121 |
|
2020
Q1 | $666K | Sell |
6,180
-960
| -13% | -$103K | 0.26% | 41 |
|
2019
Q4 | $860K | Sell |
7,140
-495
| -6% | -$59.6K | 0.26% | 45 |
|
2019
Q3 | $760K | Sell |
7,635
-300
| -4% | -$29.9K | 0.26% | 38 |
|
2019
Q2 | $866K | Sell |
7,935
-22,200
| -74% | -$2.42M | 0.27% | 37 |
|
2019
Q1 | $3.37M | Sell |
30,135
-138
| -0.5% | -$15.4K | 1.01% | 20 |
|
2018
Q4 | $2.92M | Sell |
30,273
-34,800
| -53% | -$3.36M | 1.01% | 23 |
|
2018
Q3 | $7.94M | Hold |
65,073
| – | – | 2.16% | 9 |
|
2018
Q2 | $7.16M | Hold |
65,073
| – | – | 2.06% | 9 |
|
2018
Q1 | $6.95M | Hold |
65,073
| – | – | 2.05% | 8 |
|
2017
Q4 | $6.95M | Hold |
65,073
| – | – | 2.17% | 9 |
|
2017
Q3 | $7.24M | Hold |
65,073
| – | – | 2.31% | 7 |
|
2017
Q2 | $6.73M | Sell |
65,073
-7,092
| -10% | -$733K | 2.14% | 7 |
|
2017
Q1 | $7.05M | Buy |
72,165
+360
| +0.5% | +$35.2K | 2.65% | 7 |
|
2016
Q4 | $6.35M | Buy |
71,805
+40,350
| +128% | +$3.57M | 3.74% | 5 |
|
2016
Q3 | $3.04M | Buy |
31,455
+30,000
| +2,062% | +$2.89M | 1.73% | 16 |
|
2016
Q2 | $125K | Hold |
1,455
| – | – | 0.07% | 93 |
|
2016
Q1 | $126K | Buy |
1,455
+225
| +18% | +$19.5K | 0.07% | 84 |
|
2015
Q4 | $139K | Buy |
+1,230
| New | +$139K | 0.1% | 82 |
|